Cargando…
Characterization of basigin monoclonal antibodies for receptor-mediated drug delivery to the brain
The brain uptake of biotherapeutics for brain diseases is hindered by the blood–brain barrier (BBB). The BBB selectively regulates the transport of large molecules into the brain and thereby maintains brain homeostasis. Receptor-mediated transcytosis (RMT) is one mechanism to deliver essential prote...
Autores principales: | Christensen, Sarah Christine, Krogh, Berit Olsen, Jensen, Allan, Andersen, Christian Brix Folsted, Christensen, Søren, Nielsen, Morten Schallburg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471916/ https://www.ncbi.nlm.nih.gov/pubmed/32884039 http://dx.doi.org/10.1038/s41598-020-71286-2 |
Ejemplares similares
-
Subcellular trafficking and transcytosis efficacy of different receptor types for therapeutic antibody delivery at the blood‒brain barrier
por: Holst, Mikkel Roland, et al.
Publicado: (2023) -
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies
por: Wright, Katherine E., et al.
Publicado: (2014) -
Basigin-2 is the predominant basigin isoform that promotes tumor cell migration and invasion and correlates with poor prognosis in epithelial ovarian cancer
por: Zhao, Shu-Hua, et al.
Publicado: (2013) -
Structural assembly of the megadalton-sized receptor for intestinal vitamin B(12) uptake and kidney protein reabsorption
por: Larsen, Casper, et al.
Publicado: (2018) -
Identification of ADAM12 as a Novel Basigin Sheddase
por: Albrechtsen, Reidar, et al.
Publicado: (2019)